Last reviewed · How we verify

NCT06584201

Effects of Erector Spina Plane Block and Paravertebral Block on Early Postoperative Pulmonary Function Test Parameters

Recruiting now Last updated 4 September 2024
What this trial tests

trial testing Erector Spinae Plane Block (ESP) in Respiratory Function Loss in 70 participants. Currently enrolling.

Timeline
1 November 2023
Primary endpoint
1 September 2024
1 October 2024

Quick facts

Lead sponsorBaşakşehir Çam & Sakura City Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment70
Start date1 November 2023
Primary completion1 September 2024
Estimated completion1 October 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Başakşehir Çam & Sakura City Hospital

Who can join

Adults 18 to 65, any sex, with Respiratory Function Loss or Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The pain experienced by participants after minimally invasive chest surgery (VATS) can make it difficult for them to take deep breaths, which can lead to problems with lung function. This can cause serious problems such as lung collapse, low oxygen levels, and infections, making recovery longer and more difficult. Managing pain well after surgery is important to prevent these problems and speed up recovery. In this study, we aimed to compare two pain relief methods, Erector Spinae Plane Block (ESP) and Paravertebral Block (PVB), in participants who underwent VATS. We will look at which method causes the smallest change in lung function before and after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Erector Spinae Plane Block (ESP)

Trials testing the same drug.

Other recruiting trials for Respiratory Function Loss

Currently open trials in the same condition.

Other Başakşehir Çam & Sakura City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06584201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing